Abbott's Assert-IQ offers the world's longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott's portfolio of connected health devices, the Assert-IQ ICM offers long ...

iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service. The ...

Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for its Assert-IQTM insertable cardiac monitor (ICM), giving doctors a new choice for the diagnostic assessment and ...

Abbott Laboratories (NYSE:ABT) announced Thursday that the U.S. Food and Drug Administration (FDA) cleared its Assert-IQ insertable cardiac monitor, a device to detect irregular heartbeats. Assert-IQ ...

Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced the FDA cleared its insertable cardiac monitor for diagnosis and evaluation of irregular ...

Wearlinq, maker of a wireless clinical-grade wearable 6-lead EKG, has secured a $14 million Series A investment and $5 million in venture debt funding. AIX Ventures led the Series A round, with ...

Abbott Laboratories landed CE mark for two versions of its Assert-IQ insertable cardiac monitor (ICM), one with a three-year battery life, the other lasting six years. Designed for long-term remote ...

Gaston Emergency Medical Services is the first emergency services agency in North Carolina to receive a newly developed medical device that will help paramedics save the lives of cardiac patients. The ...

GILES COUNTY, Tenn. (WKRN) — After months of back and forth, the Giles County Commission approved funding for new cardiac monitors for its emergency medcal service crews. Willow Chavez, Giles County ...